The eye allergy treatment market is anticipated to expand from US$ 3.59 billion in 2022 to US$ 5.69 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.9% during the period from 2022 to 2030.
Eye allergy treatments encompass a range of products and solutions designed to alleviate and manage allergic reactions affecting the eyes. This treatment spectrum includes both over-the-counter (OTC) medications and prescription drugs aimed at alleviating symptoms such as redness, itching, tearing, and swelling. The growth of the eye allergy treatment market is primarily driven by the rising incidence of eye allergies globally, alongside a notable trend of patients transitioning from prescription medications to OTC options. Nevertheless, the market's expansion is somewhat constrained by a general lack of awareness regarding ocular allergies and the potential side effects associated with various treatments.
In recent times, numerous initiatives have been undertaken to enhance awareness and educate the public about eye-related conditions, encouraging individuals to seek appropriate treatments. A significant portion of the population in India, particularly in rural regions, remains uninformed about eye health issues. Organizations like Sightsavers, an international NGO, are actively engaged in developing countries to combat and prevent eye diseases. Their Rural Eye Health Programme aims to raise awareness, provide quality eye care services, and eliminate preventable blindness among rural communities. Additionally, the World Health Organization (WHO) has initiated the Universal Health Coverage and Eye Care: Promoting Country Action event, which offers practical guidance to assist WHO Member States in implementing the recommendations from the WHO's World Report on Vision. Such efforts are expected to create new avenues for growth within the eye allergy treatment market.
Treatment-Based Insights
The eye allergy treatment market can be segmented based on treatment types, which include medications, allergy shots, and eye drops. In 2022, the eye drops segment accounted for a substantial share of the market and is projected to experience the highest CAGR during the forecast period. Eye drops are commonly prescribed by healthcare professionals for both the treatment and prevention of eye allergies and related conditions. The increasing levels of air pollution, including dust, pollen, and various allergens, are contributing to a rise in eye allergy cases. Eye drops are particularly effective in alleviating itchy eyes caused by allergic reactions. For instance, Dr. Reddy's Laboratories introduced Olopatadine Hydrochloride Ophthalmic Solution, an OTC eye allergy drop, in the US market in September 2020, which has positively impacted the growth of the eye allergy treatment sector.
Indication-Based Insights
From an indication perspective, the eye allergy treatment market is divided into categories such as seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, contact allergic conjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis. The seasonal and perennial allergic conjunctivitis segment held a significant market share in 2022 and is expected to register the highest CAGR from 2022 to 2030. Eye allergies occur when the immune system becomes sensitized and reacts excessively to typically harmless substances in the environment. An allergic reaction can be triggered when an allergen interacts with antibodies linked to mast cells in the eyes, leading to the release of histamine and other chemicals that cause blood vessels to leak, resulting in itchy, red, and watery eyes. Symptoms of eye allergies can overlap with those of various eye diseases, making accurate diagnosis crucial. Seasonal allergic conjunctivitis and perennial allergic conjunctivitis are the most prevalent forms of eye allergies, sharing similar symptoms but differing in the specific allergens involved. Seasonal allergic conjunctivitis is often triggered by airborne pollen, with symptoms typically surfacing in spring and summer, while perennial allergic conjunctivitis can occur year-round due to exposure to persistent allergens like mold, dust mites, and pet dander.
Treatment options for seasonal allergic conjunctivitis include antihistamines, anti-inflammatory medications, and mast cell stabilizers. For perennial allergic conjunctivitis, antihistamines are commonly prescribed, although they may exacerbate dryness if used long-term. Steroids and mast cell stabilizers may also be utilized, often requiring ongoing use throughout the year.
The eye allergy treatment market report is informed by a variety of primary and secondary sources, including the US Food and Drug Administration, the World Health Organization, and the National Health and Wellness Survey.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Eye Allergy Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Eye Allergy Treatment Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Eye Allergy Treatment Market - Global Market Analysis
6.1 Eye Allergy Treatment - Global Market Overview
6.2 Eye Allergy Treatment - Global Market and Forecast to 2030
7. Eye Allergy Treatment Market - Revenue Analysis (USD Million) - By Treatment, 2020-2030
7.1 Overview
7.2 Medication
7.3 Allergy Shots
7.4 Eye Drops
8. Eye Allergy Treatment Market - Revenue Analysis (USD Million) - By Indication, 2020-2030
8.1 Overview
8.2 Seasonal and Perennial Allergic Conjunctivitis
8.3 Vernal keratoconjunctivitis
8.4 Atopic keratoconjunctivitis
8.5 Contact Allergic Conjunctivitis
8.6 Giant Papillary Conjunctivitis
9. Eye Allergy Treatment Market - Revenue Analysis (USD Million) - By Distribution Channel, 2020-2030
9.1 Overview
9.2 Hospital Pharmacies
9.3 Online Pharmacy
9.4 Drug Stores
10. Eye Allergy Treatment Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis
10.1 North America
10.1.1 North America Eye Allergy Treatment Market Overview
10.1.2 North America Eye Allergy Treatment Market Revenue and Forecasts to 2030
10.1.3 North America Eye Allergy Treatment Market Revenue and Forecasts and Analysis - By Treatment
10.1.4 North America Eye Allergy Treatment Market Revenue and Forecasts and Analysis - By Indication
10.1.5 North America Eye Allergy Treatment Market Revenue and Forecasts and Analysis - By Distribution Channel
10.1.6 North America Eye Allergy Treatment Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Eye Allergy Treatment Market
10.1.6.1.1 United States Eye Allergy Treatment Market, by Treatment
10.1.6.1.2 United States Eye Allergy Treatment Market, by Indication
10.1.6.1.3 United States Eye Allergy Treatment Market, by Distribution Channel
10.1.6.2 Canada Eye Allergy Treatment Market
10.1.6.2.1 Canada Eye Allergy Treatment Market, by Treatment
10.1.6.2.2 Canada Eye Allergy Treatment Market, by Indication
10.1.6.2.3 Canada Eye Allergy Treatment Market, by Distribution Channel
10.1.6.3 Mexico Eye Allergy Treatment Market
10.1.6.3.1 Mexico Eye Allergy Treatment Market, by Treatment
10.1.6.3.2 Mexico Eye Allergy Treatment Market, by Indication
10.1.6.3.3 Mexico Eye Allergy Treatment Market, by Distribution Channel
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Eye Allergy Treatment Market - Key Company Profiles
13.1 Bausch and Lomb
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Alcon
13.3 Johnson and Johnson Services Inc
13.4 AbbVie
13.5 Akorn Inc.
13.6 Nicox
13.7 Santen Pharmaceutical Co. Ltd
13.8 Teva Pharmaceutical Industries Ltd
13.9 Novartis AG
13.10 Sun Pharmaceutical Industries Ltd.
14. Appendix
14.1 Glossary
14.2 About
14.3 Market Intelligence Cloud
LIST OF TABLES
LIST OF FIGURES
The List of Companies - Eye Allergy Treatment Market
Bausch + Lomb
Alcon
AbbVie
Johnson & Johnson
Akorn Inc.
Nicox
Santen Pharmaceutical Co. Ltd
Teva Pharmaceutical Industries Ltd
Novartis AG
Sun Pharmaceutical Industries Ltd.
?
